Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» ATLAS ACS 2-TIMI 51: Rivaroxaban Beneficial in Low-Risk ACS Population
ATLAS ACS 2-TIMI 51: Rivaroxaban Beneficial in Low-Risk ACS Population
ATLAS ACS 2-TIMI 51: Rivaroxaban Beneficial in Low-Risk ACS Population
Submitted by
admin
on November 13, 2011 - 12:15pm
Source:
Forbes
News Tags:
rivaroxaban
Xarelto
acute coronary syndrome
anticoagulants
anti-platelets
Headline:
ATLAS ACS 2-TIMI 51: Rivaroxaban Beneficial in Low-Risk ACS Population
Do Not Allow Advertisers to Use My Personal information
